A possible new therapeutic target for pancreatic cancer, the most lethal form of human cancer, has been identified in the proteins whose DNA recipe comes from the gene named "Seven-In-Absentia," according to researchers at the American Society for Cell Biology (ASCB) 48th Annual Meeting, Dec. 13-17, 2008 in San Francisco. In their studies with Drosophila melanogaster at the Mayo Clinic College of Medicine in Minnesota, scientists found a link between the "Seven-In-Absentia" or SINA gene and the aggressive cellular transformation, oncogenesis and metastasis that characterize pancreatic cancer. Scientists already knew that a mutation in the K-RAS gene underlies the abnormal, excessive cell growth of pancreatic cancer. Because the mutated form of this growth-promoting gene is hyperactivated, a major signaling pathway that drives cell growth is in over-drive in most patients with this cancer. The "Seven-In-Absentia-Homolog" (SIAH) protein seems to work as a check and balance mechanism in the K-RAS pathway by chewing up and turning off the excessive growth-promoting proteins produced by the hyperactive, mutated form of the gene, says Amy Tang whose Mayo lab conducted the research. "By attacking the SIAH-based protein degrading machinery, we block tumor formation in one of the most aggressive human cancers cells known," she reports. Because of these results, SIAH may be an attractive new target for novel anti-RAS and anti-cancer therapy in pancreatic cancer, the median survival of which is only six months, and the mortality rate is 95 percent. By inhibiting SIAH function, Tang and her colleagues were able to completely abolish both tumorigenesis and metastasis of human pancreatic cancer cells that were growing in "nude" mice that have immune system deficits that prevent them from rejecting foreign tissue. "It is likely to move into the clinical setting for study as an interventional treatment in pancreatic cancer in human patients," Tang says, referring to the SIAH inhibition. SINA produces a family of RING domain E3 ubiquitin ligases. In all creatures, ubiquitin ligases turn cell pathways on or off by degrading proteins. In humans, the SIAH ubiquitin ligases sit smack in the middle of the molecular pathway that leads to pancreatic cancer, Tang explains. The Tang lab found that SIAH ubiquitin ligases were specifically and markedly "upregulated" in pancreatic cancers. The increased SIAH expression seemed to correlate with increased grades and aggressiveness of pancreatic cancer. Moreover, SIAH is normally required for mammalian K-RAS signal transduction.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Small Topics on Neutrino’s for Discussion
- Systems Biology Post-Docs May Have A New Best Friend In...Philip Morris?
- Cosmos: A Spacetime Odyssey - The Review
- How Astronauts Could Try Tethered Artificial Gravity For First Time - On Soyuz Visit to ISS
- Iron Deficiency Does Not Cause People To Become Vegans
- Top Asymmetry: The Latest From DZERO
- Crystals Ripple In Response To Light
- " If an estimate is statistically significant, it’s probably an overestimate. Hank, I had to laugh..."
- "We'll see how the game changes if / when we discover rocky, liquid-water exoplanets within 25 lightyears..."
- "This is nonsense. Most of the people complaining about NSA spying are using GMail, Yahoo..."
- "Good writeup. I'll probably write up something myself from the perspective of one of us not..."
- "And then they overthrew Mubarak. I think further research is called for...."
- Education 'protects' poor women from fattening effects of rising wealth
- Deer proliferation disrupts a forest's natural growth
- New guidelines employ a team approach to autism diagnosis and care
- Research on 3D scaffolds sets new bar in lung regeneration
- New NASA Van Allen Probes observations helping to improve space weather models